Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ottawa Hospital Research Institute

Criteria

Inclusion Criteria:

● All adult and pediatric patients with an index admission to the participating hospitals during study periods

Exclusion Criteria:

• neonates

• physicians may opt out of the use of the allocated study fluid for a specific patient